Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment

Lignende værker

• The Effect of a High‐Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
  af: Gupta, Neeraj, et al.
  Udgivet: (2016)
• Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
  af: Gupta, Neeraj, et al.
  Udgivet: (2018)
• Model‐Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
  af: Gupta, Neeraj, et al.
  Udgivet: (2018)
• Switching from body surface area-based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis
  af: Gupta, Neeraj, et al.
  Udgivet: (2015)
• A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors
  af: Gupta, Neeraj, et al.
  Udgivet: (2017)